Published in Liver Transpl on November 01, 2009
Model for end-stage liver disease: end of the first decade. Clin Liver Dis (2011) 1.20
Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol (2013) 1.15
Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics (2014) 1.14
Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol (2011) 0.99
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr (2013) 0.93
Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis. Transplant Proc (2011) 0.92
Model for End-stage Liver Disease. J Clin Exp Hepatol (2012) 0.92
Current status of immunosuppression in liver transplantation. J Clin Exp Hepatol (2013) 0.86
Adoption of MELD score increases the number of liver transplant. Arq Bras Cir Dig (2014) 0.85
An analysis of tacrolimus-related complications in the first 30 days after liver transplantation. Clinics (Sao Paulo) (2014) 0.81
Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients. PLoS One (2014) 0.80
Evaluation of renal function in patients with cirrhosis: where are we now? World J Gastroenterol (2014) 0.78
Renal-sparing immunosuppressive protocol using OKT3 after liver transplantation: a 19-year single-institution experience. Proc (Bayl Univ Med Cent) (2011) 0.76
The kidney is the liver's best friend. Liver Transpl (2010) 0.75
Incidence and risk factors for early renal dysfunction after liver transplantation. World J Transplant (2016) 0.75
Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study. World J Transplant (2015) 0.75
Early acute kidney injury after liver transplantation: Predisposing factors and clinical implications. World J Hepatol (2017) 0.75
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med (2013) 11.44
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension (2008) 6.96
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut (2007) 4.51
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA (2005) 4.16
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology (2010) 3.45
The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl (2002) 3.44
A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol (2013) 3.41
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology (2007) 3.19
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol (2011) 3.16
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet (2011) 3.06
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology (2008) 2.89
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology (2002) 2.86
Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86
The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study. J Hepatol (2013) 2.82
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl (2005) 2.56
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant (2005) 2.54
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology (2012) 2.46
A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol (2008) 2.35
Management of patients with cirrhosis awaiting liver transplantation. Gut (2010) 2.34
Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl (2012) 2.32
Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl (2005) 2.31
Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology (2005) 2.29
Expanded criteria donors for kidney transplantation. Am J Transplant (2003) 2.25
Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology (2010) 2.22
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol (2012) 2.20
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut (2007) 2.09
Implementing practical interventions to support chronic illness self-management. Jt Comm J Qual Saf (2003) 2.08
Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol (2004) 2.05
Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology (2005) 2.05
Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology (2012) 2.03
Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts. Liver Transpl (2013) 2.03
An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology (2012) 2.03
Continuous Noninvasive Hemoglobin Monitoring: A Measured Response to a Critical Review. Anesth Analg (2016) 2.03
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology (2010) 2.02
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology (2012) 2.01
Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology (2003) 2.01
Outcomes in ethnic minority renal transplant recipients receiving everolimus versus mycophenolate: comparative risk assessment results from a pooled analysis. Transplantation (2013) 1.98
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol (2009) 1.96
Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. Nephrol Dial Transplant (2011) 1.96
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology (2012) 1.92
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology (2014) 1.91
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant (2004) 1.90
Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology (2006) 1.87
Cardiovascular complications after renal transplantation and their prevention. Transplantation (2006) 1.86
Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl (2003) 1.86
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet (2012) 1.85
Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology (2006) 1.85
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol (2004) 1.83
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol (2004) 1.82
Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation (2013) 1.78
Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology (2009) 1.76
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
Chronic renal dysfunction late after liver transplantation. Liver Transpl (2002) 1.74
A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol (2013) 1.72
Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology (2006) 1.71
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl (2007) 1.69
Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Hepatology (2006) 1.69
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology (2003) 1.66
Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant (2003) 1.65
Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology (2006) 1.64
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int (2008) 1.62
Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology (2010) 1.61
Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort. AIDS (2011) 1.61
Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. Hepatology (2014) 1.60
Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol (2014) 1.59
Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl (2004) 1.58
MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology (2005) 1.58
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology (2004) 1.57
Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology (2003) 1.57
Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology (2004) 1.56
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites. Hepatology (2005) 1.53
A bioartificial liver--state of the art. Science (2002) 1.53
Kidney transplant chains amplify benefit of nondirected donors. JAMA Surg (2013) 1.52
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52
Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipients. Transplantation (2012) 1.52
The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl (2007) 1.52
Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut (2012) 1.51
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation (2004) 1.51
Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology (2013) 1.50
Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation (2004) 1.50
Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol (2006) 1.50
Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc (2002) 1.49
Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl (2009) 1.48
Effect of donor kidney volume on recipient outcome: does the "dose" matter? Transplantation (2012) 1.48
Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure. Am J Kidney Dis (2008) 1.48
Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation (2009) 1.47
Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl (2013) 1.46
Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant (2003) 1.46
Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol (2008) 1.45